Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02722200 · ClinicalTrials.gov registry record · Phase 1
Investigating the Central and Peripheral Mechanisms by Which Glucocorticoids Affect Hunger
A Phase 1 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 1
- Development phase
- 28
- Enrollment target
NCT02722200 is a Phase 1 study that has completed, run by Yale University. The registered enrollment target is 28 participants.
The verdict
NCT02722200, a Phase 1 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 28 participants
- Enrollment target
Study Summary
The purpose of this study is to examine if glucocorticoids will change neural activation in regions of the corticolimbic-striatal system that regulate feeding.
Interventions
- OTHER saline
- DRUG hydrocortisone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2016-05 |
| Est. Completion | 2017-07-19 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02722200
The ClinicalTrials.gov registry entry for NCT02722200 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which saline is the first listed.
NCT02722200 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02722200 about?
NCT02722200 is a clinical study titled "Investigating the Central and Peripheral Mechanisms by Which Glucocorticoids Affect Hunger". The purpose of this study is to examine if glucocorticoids will change neural activation in regions of the corticolimbic-striatal system that regulate feeding.
What is the current status of trial NCT02722200?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 28 participants. The study started on 2016-05. Estimated completion is 2017-07-19.
What interventions are being tested in trial NCT02722200?
The interventions under investigation include: saline (OTHER), hydrocortisone (DRUG).
Who is sponsoring clinical trial NCT02722200?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.